Aromatase inhibitors and bone loss: risks in perspective.
Charles L
CL
Shapiro
D000730:Androstadienes / Q000009:adverse effects* / Q000627:therapeutic use*; D047072:Aromatase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use*; D001862:Bone Resorption / Q000139:chemically induced* / Q000517:prevention & control*; D001943:Breast Neoplasms / Q000188:drug therapy; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors
D000730:Androstadienes; D047072:Aromatase Inhibitors; C056516:exemestane